Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seagrass Technologies is a marine biotechnology company specializing in the sustainable cultivation of microalgae to produce high-value natural ingredients. The company utilizes a proprietary platform that leverages seawater and non-arable land to grow specific algae strains, such as Dunaliella salina and Haematococcus pluvialis. Their primary product portfolio includes natural beta-carotene, astaxanthin, and Omega-3 fatty acids, which serve the nutraceutical, food, and cosmetic industries. By employing eco-friendly extraction methods, Seagrass Technologies provides a sustainable alternative to synthetic additives and land-intensive crops. The firm is committed to a zero-waste circular economy model, integrating carbon capture into its production processes. Headquartered in India, the company aims to address global nutritional deficiencies through scalable marine-based solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seagrass Technologies.